Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Variant Impact
64%
Susceptibility Variants
64%
Germline Susceptibility
64%
Appendiceal Adenocarcinoma
32%
Recurrent Endometrial Cancer
32%
MiR-509-3p
32%
Omental Tumor
32%
Therapeutic Strategies
32%
Clinical Outcomes
32%
CCL24
32%
Stage III Colorectal Cancer
32%
Biological Significance
32%
Clinical Treatment
32%
Crown Structure
32%
Biological Function
32%
MiR-335
32%
Paclitaxel-induced Peripheral Neuropathy
32%
Neuroprotective Drugs
32%
Nabothian Cyst
32%
Cingulin
32%
CSF1R Gene
32%
Maternal Survival
32%
Pregnancy-associated Cancer
32%
Oncology
32%
TIMP3
32%
Small Cell Neuroendocrine Carcinoma of the Cervix
32%
Term Birth
32%
Fertility Sparing
32%
Desmoid-type Fibromatosis
32%
Mesh Exposure
32%
Transvaginal Mesh Repair
32%
Surgical Predictors
32%
Dose-escalation Study
32%
Pegylated Liposomal Doxorubicin
32%
First Relapse
32%
Peritoneal Cancer
32%
Tubal Cancer
32%
Germline Alterations
21%
Ventral Hernia
19%
Human Visceral Adipocytes
16%
Colony-stimulating Factor 1 Receptor Inhibitor
13%
Gastrointestinal Lesions
10%
Appendiceal Cancer
10%
Interval Debulking Surgery
10%
Abdominal Bloating
10%
BRCA1-associated Protein 1 (BAP1)
10%
Germline Pathogenic Variant
10%
MUTYH
10%
MSH6
10%
Colorectal Cancer Model
10%
Medicine and Dentistry
Ovarian Cancer
100%
Hazard Ratio
73%
Germ Cell
70%
Uterine Cancer
67%
Krukenberg Tumor
64%
Cancer Cell
35%
SUMO 3 Protein
32%
Oncology
32%
Peritoneum Cancer
32%
Colorectal Carcinoma
32%
Somatomedin Binding Protein 2
32%
Tumor Immunity
32%
Chlordane
32%
Bevacizumab
32%
Macrophage
32%
Term Birth
32%
Tissue Inhibitor of Metalloproteinase 3
32%
Aggressive Fibromatosis
32%
Hereditary Nonpolyposis Colorectal Cancer
32%
Biological Functions
32%
Paramethasone
32%
Colony Stimulating Factor 1
29%
DNA Mismatch Repair
26%
Drug Resistance
24%
Malignant Neoplasm
24%
Proportional Hazards Model
22%
microRNA
21%
Neoplasm
21%
4 Amino 6 [2 [[4 (Diethylamino) 1 Methylbutyl]amino] 6 Methyl 4 Pyrimidinyl] 2 Methylquinoline
19%
Carcinoma Cell
18%
Cisplatin
17%
Univariate Analysis
16%
Multivariate Analysis
16%
Gene Repair
16%
Hematoma
16%
Uterus Tumor
16%
Local Excision
16%
Pelvic Examination
16%
Tumor Microenvironment
16%
Hysterectomy
16%
Overall Survival
15%
Tumor Progression
15%
Phosphoinositide Dependent Protein Kinase 1
13%
First Year Postpartum
12%
Scatter Factor
12%
Ovarian Tumor
12%
Macrophage Polarization
10%
Bloating
10%
Family History
10%
Heterodimer
10%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
96%
Germline
64%
Germ Cell
64%
Drug Resistance
64%
Collagen, Type XI, Alpha 1
43%
Overall Survival
43%
MicroRNA
43%
DNA Methyltransferase
32%
DNA Mismatch Repair
32%
Downregulation
32%
Ubiquitin
32%
CD163
32%
Cingulin
32%
Colony Stimulating Factor 1 Receptor
32%
Tumor Immunity
32%
Insulin-Like Growth Factor-Binding Protein
32%
Fibroblast
32%
MLH1
32%
Classification Algorithm
32%
MSH6
32%
Laboratory Test
25%
Phosphoinositide-Dependent Kinase-1
24%
Gene Repair
19%
PMS2
19%
Transcription
18%
Cisplatin
18%
Cell Growth
18%
Tumor Progression
16%
Cancer Registry
16%
Promoter Region
13%
Cancer Screening
12%
Germline Mutation
12%
Cell Invasion
11%
Cell Proliferation
11%
Methylation
10%
mRNA Expression Level
10%
Transcription Regulation
10%
Quantitative Reverse Transcription Polymerase Chain Reaction
10%
Chemosensitivity
10%
RNAI
10%
Site-Directed Mutagenesis
10%
Luciferase
10%
Chromatin Immunoprecipitation
10%
Non-Coding RNA
10%
In Vivo Study
10%
Plasmid
10%
Messenger RNA
8%
Cancer Staging
8%
Protein Kinase B
8%
MMP3
8%
